Research News
View articles by month and year
-
Exercising with Others Improves Well-Being During Treatment
Regular group exercise can improve quality of life for women with breast cancer.
-
Aromatase Inhibitors Offer Better Survival Than Tamoxifen for Postmenopausal Women
Switching to an aromatase inhibitor after two to three years of tamoxifen offers improved survival compared to five years of tamoxifen for post-menopausal women with hormone-receptor-positive, early-stage breast cancer.
-
Actonel Can Help Stop Bone Loss After Treatment
Actonel (chemical name: risedronate) helps prevent bone loss in women undergoing breast cancer treatment.
-
Newly Approved MammaPrint Test Can Help Determine Risk of Recurrence
The U.S. Food and Drug Administration has approved MammaPrint, a test that helps predict whether early breast cancer will come back.
-
Slight Drop in U.S. Mammogram Rate Troubles Experts
The percentage of women over 40 who get regular mammograms has declined, which is troubling.
-
Risk of Second Cancer Higher in Men Diagnosed with Breast Cancer
Men who have been diagnosed with breast cancer have a higher risk of developing a second, new cancer.
-
Protein Test May Help Guide Triple-Negative Breast Cancer Treatment Decisions
A specific protein has been linked to triple negative breast cancer (cancers that test negative for estrogen receptors, progesterone receptors, and the HER2 protein).
-
Very Dense Breasts Linked to Higher Risk
Breast density makes mammograms harder to read and also seems to increase breast cancer risk.
-
Too Many Women Stop Taking Tamoxifen Early
Many women stop taking adjuvant hormonal therapy medicine earlier than prescribed by their doctors.
-
Poorly Educated and Obese Women Get Lower Chemo Doses
Women with breast cancer who are either obese or have little education are more likely to get lower than recommended doses of chemotherapy.
